rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
7
|
pubmed:dateCreated |
2009-7-20
|
pubmed:abstractText |
The objective of this study was to determine whether infliximab, an antitumor necrosis factor monoclonal antibody, is transferred in utero or through breast milk from nursing Crohn's disease patients to their newborns.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
1539-2031
|
pubmed:author |
|
pubmed:issnType |
Electronic
|
pubmed:volume |
43
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
613-6
|
pubmed:meshHeading |
pubmed-meshheading:19142167-Adult,
pubmed-meshheading:19142167-Anti-Inflammatory Agents,
pubmed-meshheading:19142167-Antibodies, Monoclonal,
pubmed-meshheading:19142167-Crohn Disease,
pubmed-meshheading:19142167-Enzyme-Linked Immunosorbent Assay,
pubmed-meshheading:19142167-Female,
pubmed-meshheading:19142167-Follow-Up Studies,
pubmed-meshheading:19142167-Humans,
pubmed-meshheading:19142167-Infant, Newborn,
pubmed-meshheading:19142167-Maternal-Fetal Exchange,
pubmed-meshheading:19142167-Milk, Human,
pubmed-meshheading:19142167-Pregnancy,
pubmed-meshheading:19142167-Pregnancy Complications,
pubmed-meshheading:19142167-Prospective Studies,
pubmed-meshheading:19142167-Young Adult
|
pubmed:year |
2009
|
pubmed:articleTitle |
Absence of infliximab in infants and breast milk from nursing mothers receiving therapy for Crohn's disease before and after delivery.
|
pubmed:affiliation |
Department of Medicine, Mayo Clinic College of Medicine, Rochester, MN 55905, USA. Kane.Sunanda@mayo.edu
|
pubmed:publicationType |
Journal Article,
Case Reports,
Research Support, Non-U.S. Gov't
|